References
- ALEX, R. and BODMEIER, R., 1990, Encapsulation of water-soluble drugs by a modifies solvent evaporation method. I. Effect of process and formulation variables on drug entrapment. Journal of Microencapsulation, 7, 347–355.
- DALPIAZ, A., SCATTURIN, A., PAVAN, B., BIONDI, C., VANDELLI, M. A. and FORNI, F., 2001, Poly(lactic acid) microspheres for the sustained release of a selective Al receptor agonist. Journal of Controlled Release, 73, 303–313.
- DENG, X., ZHOU, S., LI, X., ZHAO, J. and YUAN, M., 2001, In vitro degradation and release profiles for poly-dl-lactide-poly(thylene glycol) microspheres containing human serum albumin. Journal of Controlled Release, 71, 165–173.
- DENG, X. M., LI, X. H., YUAN, M. L., XIONG, C. D., HUANG, Z. T., JIA, W. X. and ZHANG, Y. H., 1999, Optimization of preparative conditions for poly-DL-lactide-polyethylene glycol microspheres with entrapped Vibrio Cholera antigen. Journal of Controlled Release, 58, 123–131.
- DENG, X. M., XIONG, C. D., CHENG, L. M. and XU, R. P., 1990, Synthesis and characterization of block copolymers from D,L-lactide and poly(ethylene glycol) with stannous chloride. Journal of Polymer Science, 28, 411–416.
- EDWARDS, D. A., BEN-JEBRIA, A. and LANGER, R., 1998, Recent advances in pulmonary drug delivery using large, porous inhaled particles. Journal of Applied Physiology, 84, 379–385.
- EDWARDS, D. A., HANES, J., CAPONETTI, G., HIKACH, J., BEN-JEBRIA, A., LOTAN, N., ESKEW, M. L., ULTMAN, J. and LANGER, R., 1997, Large porous aerosols for pulmonary drug delivery. Science, 276, 1868–1871.
- KAWASHIMA, Y., YAMAMOTO, H., TAKEUCHI, H., FUJIOKA, S. and HINO, T., 1999, Pulmonary delivery of insulin with nebulized DL-lactide/glycolide copolymer (PLGA) nanospheres to prolong hypoglycemic effect. Journal of Controlled Release, 62, 279–287.
- KEEFER, L. K., 1998, Nitric oxide-releasing compounds: from basic research to promising drugs. Chemtech, 28, 30–35.
- KEEFER, L. K., RAYMOND, W., DAVIES, K. M. and WINK, D. A., 1996, `NONOates' (1-substituted diazen-1-ium-1,2-diolates) as nitric oxide donors: convenient nitric oxide dosage forms. In Methods in Enzymology (Washington: Academic Press). pp. 281–293.
- MAA, Y.F. and Hsu, C., 1996, Liquid—liquid emulsification by rotor/stator homogenization. Journal of Controlled Release, 38, 219–228.
- MAA, Y.F. and Hsu, C. C., 1997, Effect of primary emulsions on microsphere size and protein-loading in the double emulsion process. Journal of Microencapsulation, 14, 225–241.
- MIRVISH, S. S., BULAY, 0., RUNGE, R. G. and PATLI, K., 1980, Study of the carcinogenicity of large doses of dimethylnitramine, N-nitoso-L-proline, and sodium nitrite administered in drinking water to rats. Journal of the National Cancer Institute, 64, 1435–1442.
- MONCADA, S. and HIGGS, E. A., 1995, Molecular mechanisms and therapeutic strategies related to nitric oxide. FASEB Journal, 9, 1319–1330.
- MOORADIAN, D. L., HUTSELL, T. C. and KEEFER, L. K., 1995, Nitric oxide (NO) donor molecules: effect of NO release rate on vascular smooth muscle cell proliferation in vitro. Journal of Cardiovascular Pharmacology, 25, 674–678.
- RUBANYI, G. M., 1991, Endothelium-derived relaxing and contracting factors. Journal of Cellular Biochemistry, 46, 27–36.
- SAAVEDRA, J. E., SOUTHAN, G. J., DAVIES, KM., LUNDELL, A., MARKOU, C., HANSON, SR., ADRIE, C., HURFORD, W. E., ZAPOL, W. M. and KEEFER, L. K., 1996, Localizing antithrombotic and vasodilatory activity with a novel, ultrafast nitric oxide donor. Journal of Medical Chemistry, 39, 4361–4365.
- ZAPOL, W. M. and HURTFORD, W. E., 1994, Inhaled nitric oxide in adult respiratory distress syndrome and other lung diseases. Advances in Pharmacology, 31, 513–530.